Honluten

Longevity & Cellular Health

Also known as: Honluten Cytogen, Respiratory Cytogen

Bioregulators (Khavinson Peptides)Research phase: Clinical use in Russia, no Western trialsRegulatory: Not FDA-approved. Available as bioregulator supplement in Russia and from international suppliers.

Mechanism

Honluten is a synthetic short-chain peptide cytogen for respiratory bioregulation. It is designed to support bronchopulmonary tissue health and respiratory function through targeted peptide signaling at the gene expression level.

Technical detail

Honluten is a cytogen-class bioregulator consisting of a defined synthetic tripeptide (Glu-Asp-Gly) that targets bronchopulmonary tissue gene expression. It is proposed to normalize respiratory epithelial cell differentiation, support mucociliary clearance mechanisms, and modulate local immune surveillance in the airways. It complements Bronchogen (cytogen with a different sequence), Chonluten (lung cytogen), and Bronchamin (cytamin) in the Khavinson respiratory bioregulator product line.

Evidence

  • Peptide regulation of gene expression and protein synthesis in bronchial epithelium.

    Khavinson VKh et al. (2014) — Lung — PMID: 25015171

    This PubMed-indexed mechanistic study evaluated the ADEL tetrapeptide associated with Honluten in human bronchial epithelial cell cultures and reported regulation of proliferation, anti-apoptotic signaling, and differentiation-related genes including NKX2-1, SCGB1A1, SCGB3A2, FOXA1, FOXA2, MUC4, MUC5AC, and SFTPA1. The findings support a tissue-targeted respiratory bioregulation rationale, but the evidence remains preclinical and should not be read as proven human clinical benefit.

    moderate
Build a personalized protocol with Honluten →